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ABSTRACT 
In this report, we introduce a method using nano-scale ion-pair reversed-phase high-
performance liquid chromatography (nano-IP-RP-HPLC), hyphenated to nano-
electrospray ionization high-resolution mass spectrometry (nano-ESI-HRMS) to separate 
and identify metabolites in cell extracts. Separation of metabolites was performed on a 
100 µm i.d. C18 column with tributylamine (TBA) as ion-pairing reagent and methanol as 
eluent. Basic pH (9.4) of the mobile phase was critical to achieve sufficient retention and 
sharp metabolite elution at low concentration of TBA (1.7 mM). Limits of detection were 
determined for 54 standards with an LTQ-Orbitrap mass spectrometer to be in the upper 
attomol to low femtomol range for key metabolites such as nucleotides, phosphorylated 
sugars, organic acids, and coenzyme A thioesters in solvent as well as in complex 
matrix.  To further evaluate the method, metabolome analysis was performed injecting 
different amounts of biomass of the methylotroph model organism Methylobacterium 
extorquens AM1. A 12C/13C labeling strategy was implemented to improve metabolite 
identification Analysis of three biological replicates performed with 1.5 ng cell dry weight 
biomass equivalents resulted in the identification of 24 ± 4 metabolites and analysis of 
150 ng allowed identifying 157 ± 5 metabolites from a large spectrum of metabolite 
classes.  
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INTRODUCTION  
Mass spectrometry (MS) is a key technology and driving force for the fast prospering 
field of metabolomics. In the last decade, great progress has been made, both with respect to 
mass spectrometry as well as to chromatographic methods coupled to mass spectrometry to 
analyze complex biological samples. In particular, high-performance liquid-chromatography 
(HPLC) technology underwent rapid development. Miniaturization of column diameters and 
concomitant reduction in flow rates below 1 µL/min (typically 20-500 nL/min) allowed nano-
electrospray ionization (nano-ESI). The latter generally improves the ionization process, 
reduces ion suppression effects,1 and increases tolerance towards salt contaminations in the 
sample.2, 3 In LC-MS based proteomics, nano-flow reversed phase HPLC coupled to nano-ESI 
mass spectrometry is the method of choice.4-7 Due to miniaturization sensitivities at low 
zeptomol level could be achieved for individual proteins upon detection of proteolytic peptides.8 
Usually, peptides are separated using C18 stationary phases combined with aqueous mobile 
phases acidified with formic acid, or trifluoroacetic acid and using acetonitrile or methanol as 
organic modifier. In contrast, metabolites comprise a large range of compounds with various 
physico-chemical properties demanding different separation mechanisms. Central metabolites 
such as sugar phosphates, amino acids or small organic acids are highly polar. They can 
therefore not be retained on reversed-phase stationary phases. Good chromatographic 
separation of central metabolite classes are obtained by ion chromatography (IC),9, 10  or by 
hydrophilic interaction liquid chromatography (HILIC).11-13 However, both separation techniques 
are currently not well suited for nano-flow application. To our knowledge, nanobore IC columns 
and corresponding ion suppressors are not yet commercially available. In case of HILIC, loading 
capacity is rather low which reduces its applicability in nano-scale dimension.14 So far only two 
nano-HPLC-MS methods were reported for analysis of highly polar metabolites on self-packed 
columns (anion exchanger or mixed functional RP with cation exchanger) achieving limits of 
detection in the sub picomol to low picomol range.14, 15 
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Ion-pair reversed-phase (IP-RP) HPLC offers an attractive principle for nano-ESI based 
metabolome analysis. Amphiphilic amines are generally used to retain negatively charged 
compounds.16-18 In two recently published studies, tributylamine (TBA) was used as ion-pairing 
reagent for HPLC-ESI-MS analysis in the negative ionization mode allowing the analysis of 
more than 100 core metabolites.19, 20 Ion-pairing with hexylamine was investigated by Coulier et 
al. for the analysis of various metabolite classes such as nucleotides or sugar bisphosphates.21  
Gu et al. used perfluoroheptanoic acid for ion-pair reversed-phase analysis of amino acids and 
metabolically related compounds in the positive ionization mode, obtaining limits of detections in 
the sub-picomol range for most of analytes tested when using a 2 mm i.d. C18 column.22 
Nanobore columns based on C18 stationary phases have high robustness, sufficient loading 
capacities, and they are used routinely in nano-scale HPLC-MS based proteomics. Since ion-
pairing is mainly based on C18 stationary phases, the IP-RP approach is promising for nano-
scale HPLC-MS linked metabolomics. In the present study, we developed a nano-HPLC-ESI-
MS method for central metabolome analysis in the negative ionization mode using TBA as ion-
pairing reagent. Limits of detection obtained were in the low femtomol down to hundreds of 
attomol range for all metabolites tested. Compared to a previous HPLC-MS based metabolome 
analysis of a model bacterium12,  sample amount per injection could be reduced by a factor of 
more than 1'000. The study demonstrates the potential of downscaling HPLC-MS methods for 
metabolome analysis. The introduced method thus opens the perspective to pioneer 
investigation of biological samples for which only limited amounts are available.  
 
EXPERIMENTAL SECTION 
Chemicals. Reference standards of the various metabolites as well as acetonitrile (LC-
MS grade), formic acid (≥ 88%), acetic acid (≥ 99.0%), and tributylamine (≥ 99.5%) were 
purchased by Sigma-Aldrich Chemie GmbH (Buchs, Switzerland). Uniformly 13C labeled 
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methanol was obtained through Cambridge Isotope Labs Inc. (Innerberg, Switzerland). 
Ammonia solution (25%) was purchased by Merck KGaA (Darmstadt, Germany) and methanol 
(LC-MS grade) was supplied by Fisher Scientific UK Limited (Loughborough, United Kingdom).  
Medium and growth conditions. Methylobacterium extorquens AM1 was grown on 
minimal medium using 120 mM methanol as carbon source.23 400 mL batch culture was 
performed in 500 mL Multifors bioreactor (Infors HT, Switzerland) (temperature 28 °C, stirring 
rate 1000 rpm, aeration rate 0.5 L/min). The pH was maintained at pH 7 by addition of 1 M 
ammonium hydroxide.  
Sample preparation. Cells were sampled during mid-exponential growth. Optical 
density of the culture was determined at 595 nm prior to sampling. 1 mL of culture was directly 
injected into 4.5 mL of -20°C cold acidified acetonitrile with 0.1 M formic acid.24 Prior to 
extraction, uniformly 13C labeled cell extract (M. extorquens AM1 grown on uniformly 13C labeled 
methanol obtained by the same protocol) was added to the sample. For extraction samples 
were incubated 15 min on ice  and subsequently freeze dried and stored at -20°C until analysis. 
Samples were re-suspended in deionized water adjusting cell dry weight concentration to 10 
µg/µL. Cell debris and other insoluble parts were separated by centrifugation (10 min, 20’000 g, 
4°C).  Prior to injection, samples were diluted with solvent A as indicated below. The correlation 
of the optical-density and cell-dry-weight was determined to be 0.27 mg/mL.  
HPLC-MS analysis. Nanoflow high-performance liquid chromatography nanospray high-
resolution mass spectrometry analysis was carried out with a split-free nanoLC Ultra system 
(Eksigent, Dublin, CA) hyphenated to an LTQ-Orbitrap mass spectrometer (ThermoFisher 
Scientific, San Jose, CA). For HPLC separation, a C18 column was used as stationary phase 
(Thermo Hypersil gold 150 x 0.1 mm i.d., 5 m particle size, pH range 1-11). For nanospray 
ionization the column was connected via liquid junction to a silica tip emitter (20 m i.d., tip 10 ± 
1 m, New Objective, Woburn, MA). Tributylamine (TBA) was employed as reagent for ion-pair 
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reversed-phase (IP-RP) separation. Solvent A was obtained by dissolving 1.7 mM TBA in 1.5 
mM acetic acid and solvent pH was subsequently adjusted to pH 9.4 with 6 M ammonium 
hydroxide. Eluent B was methanol and varied as follows: 0 min, 3 %; 30 min, 90 %; 35 min, 90 
%; 36 min, 3 %; 45 min, 3%. Injection volume was 1 L. Mass acquisition was carried out in the 
negative FTMS mode at unit resolution of 60’000 (at m/z 400) applying ion spray voltage of -1.9 
kV. Capillary temperature was 150 °C and capillary voltage was set at -10 V. To increase 
sensitivity of the mass spectrometer, acquisition was performed in single ion monitoring mode 
(SIM) for three different scan ranges. For high mass ranges (202 ≤ m/z ≤ 650, and 600 ≤ m/z ≤ 
1’000) tube lens voltage was -100 V. Tube lens voltage was reduced to -60 V for the scan range 
100 ≤ m/z ≤ 350. 
Limit of detection (LOD). To determine LOD, dilution series of standard mixtures were 
prepared using solvent A. To determine LOD in complex matrix, cell extract from M. extorquens 
AM1 grown on 13C methanol was diluted 10-fold with solvent A to a final concentration of 1 
µg/µL biomass cell dry weight equivalent, and this solution was used to prepare dilution series 
of standard mixtures.  Mass isomers were injected separately to avoid peak overlapping. Prior 
to sample analysis blanks (solvent) were injected to examine for eventual presence of analytes 
in solvent or in the analytical system. Dilution series of standard mixtures were carried out 
starting with the lowest concentration. For several compounds (i.e. citric acid and succinic acid), 
monoisotopic peaks M0 were always present in the blank. Therefore, concentrations of uniformly 
13C labeled peaks MUL were determined in 
13C cell extract using the isotope dilution method 25, 26 
and LOD of MUL in 
13C cell extract dilution series was determined instead.    
Identification of potential metabolites in cell extracts. Potential metabolites were 
identified by stable 13C isotope assignment.27, 28  For attribution of molecular formulas to 
detected mass peaks, a list of 14’943 molecular formulas was extracted from PubChem 
compound database (http://pubchem.ncbi.nlm.nih.gov/) from all compounds of category 
metabolic pathways composed of C and H, N, O, P, or S. The list was used to generate mass 
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lists for assignment of molecular formulas. A molecular formula of the database was assigned to 
a mass peak when i. the differences between theoretical and measured m/z values of the 
monoisotopic peak M0, of the corresponding U-
13C labeled peak MUL as well as the delta value 
MUL-M0 were below 1
 mmu, and ii. peaks of M0 and of MUL had the same retention time. 
Chromatographic peaks were considered for identification when signal to noise ratio of 
monoisotopic peak and uniformly 13C labeled peak were at least three. As mass drifts occurred 
during data acquisition, identification was improved by correcting measured m/z values using 
mass peaks with known m/z values present in the U-13C labeled cell extract. 
 
 
RESULTS AND DISCUSSION 
Evaluation of nano-scale IP-RP HPLC-MS with standards. For IP-RP based HPLC 
separation, tributylamine (TBA) was chosen as ion pairing reagent. To achieve efficient pairing 
between analytes and TBA (pKa 10.4), analytes should be negatively charged and tributylamine 
positively charged. As many metabolites have a pKa ~6 (e.g. phosphorylated sugars) or even 
pKa ~9 (e.g. nucleotides), pH was set to pH 9.4 and a C18 stationary phase stable under basic 
conditions was used. Since ion-pairing reagents cause ion suppression effects and thus 
significantly reduce sensitivity of HPLC-MS29, the minimal concentration of TBA in the mobile 
phase providing retention of metabolites was added (1.7 mM). The method was evaluated using 
a 100 µm i.d. column and a flow rate of 500 nL/min. Under these conditions, retention times of 
standard compounds from various metabolite classes such as organic acids, phosphorylated 
compounds, sugar derivates, or coenzyme A (CoA) thioesters on the column were measured 
(Table 1). Chemically related compounds are generally eluting in the same separation window, 
indicating similar retention behavior. Organic acids eluted between 16 and 20 min, whereas 
CoA thioesters were detected in the 21-23 min time range. Nucleotide monophosphates eluted 
first (15-16 min), followed by nucleotide diphosphates (18-19 min) and nucleotide triphosphates 
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(19.3 min). The additional charges in nucleotide triphosphates compared to nucleotide 
monophosphates provide a better ion-pairing with TBA cations and retention was increased. 
The chromatographic separation resulted in sharp elution profiles (see also Figure 1), 
separating most of the metabolites (Table 1). Notably however, incomplete chromatographic 
separation of metabolites with different m/z values is principally not of concern, since data 
acquisition with a high accuracy mass spectrometer allows the display of extracted ion 
chromatograms for the compound of interest. Separation of mass isomers such as glucose-6-
phosphate and fructose-6-phosphate was generally not achieved and only one peak was 
observed in the corresponding extracted ion chromatogram (see Figure 1, hexose-6-
phosphate). In some cases, MS/MS experiments might allow distinguishing between co-eluting 
mass isomers by compound specific fragment ions. For such purpose, hyphenation of the nano-
IP-RP-HPLC setup with a triple quadrupole instrument can be envisaged in order to perform 
multiple reaction monitoring experiments (MRM). For nucleotides (e.g. ADP), two peaks were 
generally observed (Figure 1). The first peak is assigned to adenosine diphosphate (ADP), 
whereas the second one is due to in-source fragmentation of adenosine triphosphate (ATP). 
Reduction of the transfer tube temperature reduced ATP fragmentation; however, the 
phenomenon could not be completely eliminated. This is not of concern, since ATP and ADP 
are chromatographically almost baseline separated and fragmentation did not hamper 
determination of the nucleotides. This is of major importance when applying the method for 
quantitative analysis, as ATP/ADP ratios are often determined to evaluate energetic states of 
cells. Similarly, ADP fragmention results in AMP detection (Figure 1).  
Limits of detection were determined for 54 commercially available metabolites (Table 1). 
Most of these were detected in the upper attomol range. Compared to state of the art HPLC-MS 
methods based on hydrophilic liquid chromatography (HILIC) or ion-pair reversed-phase liquid 
chromatography employing 2 mm i.d. columns,12, 19, 20 sensitivity is thus drastically increased 
with nanoscale HPLC-MS. Except for fumarate, all investigated compounds had limits of 
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detection significantly lower than those determined with other analytical setups (Table 2). 
Detection sensitivity was generally several hundred times higher and for some metabolites (e.g. 
ADP) LOD was even increased by a factor of several thousands. As mass spectrometers 
employed in the previous studies are either equivalent (Orbitrap and Exactive, ThermoFisher 
Scientific, San Jose, CA) or even more detection sensitive (TSQ Quantum, ThermoFisher 
Scientific), increase in detection sensitivity achieved in the present study is not due to the MS 
instrument itself but to preceding nano-IP-RP-HPLC coupled to nanospray ionization. 
In a second step, limits of detection were investigated in a complex matrix. To this end, 
metabolite standards were diluted with cell extract of Methylobacterium extorquens AM1 grown 
on 13C labeled methanol. As expected, a decrease in sensitivity was observed but limits of 
detection were still in the 0.1-10 fmol range for most metabolites; CoA thioesters, however, 
which play a central role in the assimilatory metabolism during growth of one carbon 
compounds of M. extorquens AM124 were even detected below 1 fmol. Exemplarily, linearity 
was investigated for 15 compounds in complex matrix revealing a linear concentration range 
between 2-3 orders of magnitude when using the LTQ Orbitrap instrument (see Table S1).  
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Table 1. Limits of detection for 54 standard metabolites in alphabetical order. LOD's were determined in aqueous 
solution without and with complex matrix (uniformly 13C labeled cell extract from 500 ng CDW of M. extorquens AM1). 
 
metabolite formula RT [min] LOD [amol] MF detected in cell extract 
a
 
   solvent A complex 
   matrix 
0.5 
ng/inj. 
5 
ng/inj 
50 
ng/inj. 
250 
ng/inj. 
2-deoxyribose-5-phosphate C5H11O7P 15.0 500 2’500 - 3 3 3 
2-oxoglutaric acid C5H6O5 16.3   2’500 5’000 - - - - 
3-hydroxybutyric acid C4H8O3 16.8 25’000
 b
  - - - 3 
3-hydroxybutyryl-CoA C25H42N7O18P3S 21.1 100 250 - 3 3 3 
3-phosphoglycerate C3H7O7P 18.2 7’500 2’500 - 2 3 3 
6-phosphogluconate C6H13O10P 18.9 750 2’500 - 3 3 3 
acetyl-CoA C23H38N7O17P3S 21.2 100 250 3 3 3 3 
acetoacetyl-CoA C25H40N7O18P3S 21.0 250    1’000 - - - - 
adenine di-phosphate C10H15N5O10P2 19.0 250 100 - 1 3 3 
ADP-ribose C15H23N5O14P2 17.1 250 500 - - 3 3 
adenine mono-phosphate C10H14N5O7P 16.5 100 250 1 3 3 3 
adenine tri-phosphate C10H16N5O13P3 19.4 750 2500 3 3 3 3 
aspartic acid C4H7NO4 8.1 25’000  - - 1 - 
butyryl-CoA C25H42N7O17P3S 22.5 100 100 - - 3
c
 3
c
 
biotin C10H16N2O3S 15.9 500 750 - - - - 
cADP-ribose C15H21N5O13P2 12.4 5’000 5’000 - - 3 3 
cAMP C10H12N5O6P 16.0 250 500 3 3 3 3 
cGMP C10H12N5O7P 14.1 250 500 - 2 3 3 
cis-aconic acid C6H6O6 18.6   5’000
 b
  - 3 3 3 
citric acid/ isocitric acid C6H8O7 19.8   5’000
 b
  - 3 3 3 
crotonyl-CoA C25H40N7O17P3S 22.1 250 250 - - 3 3 
cytidine di-phosphate C9H15N3O11P2 18.0 5’000 2’500 - - 3 3 
cytidine mono-phosphate C9H14N3O8P 15.3 500 2’500 - 3 3 3 
cytidine tri-phosphate C9H16N3O14P3 19.3     500 1’000 - 3 3 3 
dihydroxyacetone phosphate C3H7O6P 19.3 2’500 7’500 - - 3 3 
ethylmalonic acid C5H8O4 16.7  5’000
 b
  3 3 3 3 
erythrose-4-phosphate C4H9O7P 15.4 7’500  - - - - 
FADH C27H33N9O15P2 19.3 100 250 - 3 3 3 
fructose-6-phosphate C6H13O9P 15.1 500 1’000 3
c
 3
c
 3
c
 3
c 
fructose-1,6-bisphosphate C6H14O12P2 19.7 500 750 - - 3 3 
fumaric acid C4H4O4 17.0 40’000
 b
  - - - - 
glucose-6-phosphate C6H13O9P 15.0 500 500 3
c
 3
c
 3
c
 3
c
 
glutamic acid C5H9NO4 8.0 25’000  - - 3 3 
guanidine di-phosphate C10H15N5O11P2 18.4 500 750 - 3 3 3 
guanidine mono-phosphate C10H14N5O8P 15.4 500 2’500 - - 3 2 
guanidine tri-phosphate C10H16N5O14P3 19.2 750 2’500 1 3 3 3 
isobutyryl-CoA C25H42N7O17P3S 22.5 200 100 - - 3
c
 3
c
 
malic acid C4H6O5 17.5 10’000
 b
  - 3 3 3 
methylmalonyl-CoA C25H40N7O19P3S 21.4         300 100 - 3
c
 3 3
c
 
NAD C21H27N7O14P2 12.3 250 500 2 3 3 3 
oxoglutathione C20H32N6O12S2 16.5 250 500 3 3 3 3 
pantothenic acid C9H17NO5 14.1 100 250 3 3 3 3 
phosphoenol pyruvate C3H5O6P 18.3 5’000 5’000 - - 3 3 
phosphoserine C3H8NO6P 16.0 7’500 5’000 - - -  
propionyl-CoA C24H40N7O17P3S 21.7   50 100 - 3 3 3 
pyridoxal phosphate C8H10NO6P 18.3 5’000  - 1 3 1 
ribose-5-phosphate C5H11O8P 15.9 500 1’000 - 3
c
 3
c
 3
c
 
ribulose-5-phosphate C5H11O8P 15.3 500 2’500 - 3
c
 3
c
 3
c
 
succinyl-CoA C25H40N7O19P3S 21.3 300 750 - 3
c
 3 3
c
 
trehalose-6-phosphate C12H23O14P 15.0 250 750 3 3 3 3 
uridine-di-phosphate C9H14N2O12P2 18.1 250 500 - 3 3 3 
uridine-mono-phosphate C9H13N2O9P 15.4 100 2’500 - 1 3 3 
uridine-tri-phosphate C9H15N2O15P3 19.3 250 750 1 3 3 3 
xylulose-5-phosphate C5H11O8P 15.6 500 2’500 - 3
c
 3
c
 3
c
 
         
a 
How often a MF was detected in 3 analyses performed with a given amount of biomass per injection (ng/inj.). 
 b 
LOD determined by U-13C mass 
peak of 13C cell extract using isotope dilution for quantification. 
c 
Co-eluting mass isomers that cannot be distinguished by the method. 
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Table 2. Comparing limits of detection by HPLC-ESI-MS and by nano-HPLC-ESI-MS. Values 
are expressed in fmol. 
 
metabolite separation with IP-RP or 
HILIC on 2 mm i.d. 
columns
12, 19, 20
 
separation with IP-RP on 0.1 
mm i.d. column (this study) 
   
2-oxoglutarate 250-4’100 1 
3-phosphoglycerate 1’000 2.5 
6-phosphogluconate 460-750 0.25 
acetyl-CoA 124-12’300 0.1 
adenosine diphosphate (ADP) 460-2’940 0.1 
adenosine monophosphate (AMP) 51-342 0.1 
adenosine triphosphate (ATP) 3’950-4’100 0.5 
aspartate 17-151 25 
citrate 250-10’400 5 
dihydroxyacetone phosphate 750-2’940 2.5 
fructose 1,6-bisphosphate 150-589 0.25 
glucose 6-phosphate 38-100 0.1 
glutamate 100-1’400 25 
phosphoenol pyruvate 51-595 2.5 
ribose 5-phosphate 43-100 0.1 
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Application of the method to metabolome analysis of a model bacterium. To 
investigate the potential of the developed method, cell extracts of the model strain 
M. extorquens AM1 were analyzed. A critical question was the sensitivity of the method for true 
biological samples.  Since the LTQ-Orbitrap instrument with its high mass resolution (up to 
100’000 at m/z 400) is particularly suited for compound identification,30 we investigated the 
suitability of the above-described method and correlated the number of detected metabolites 
with the amount of the analyzed biomass. Stable carbon isotope labeling was combined with 
high-resolution mass spectrometry to assign molecular formulas (MF) to detected mass peaks 
(see experimental section). To this end M. extorquens AM1 was grown on methanol as sole 
carbon source. Three samples were taken during exponential growth, quenched and extracted. 
Prior to extraction, 99 % 13C labeled cell extract from similar biomass amount was added to the 
samples.  All samples were diluted to final cell dry weight concentrations of 0.5 ng/µL, 5 ng/µL, 
50 ng/µL, and 250 ng/µL, respectively. Dilution series of each sample were analyzed by the 
introduced HPLC-MS method and numbers of detected molecular formulas were determined for 
each sample (Table 3).  
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Table 3. Metabolome analysis of M. extorquens AM1. Number of identified molecular formulas 
(MF) in dilution series of cell extracts of three different samples. CDW/inj., cell dry weight 
equivalent of injected sample amount; 1 (2, 3) out of 3, number of samples in which MF was 
detected; Σ, total of MF identified at least in one out of three analyzed samples. 
 
CDW/inj. [ng] 
 
average ± SD 
 
3 out of 3 2 out of 3 1 out of 3 Σ 
0.5 20 ± 4 17 1 6 24 
5 67 ± 2 65 2 6 73 
50 157 ± 5 142 14 17 173 
250 149 ± 4 136 15 7 158 
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Details concerning the identified MF in analyzed dilution series are available as 
supporting information (TablesS2-S5). Since databases play a key role in metabolite 
identification, the structure of the database used in the present study is described in the 
experimental section. With 0.5 ng CDW per injection an average of  20 MF was identified and 
17 MF were detected in all 3 analyzed samples. The number of identified MF increased with 
injected biomass amount until 50 ng CDW per injection where average number of identified 
molecular formulas was 157 ± 5. Further increase of injected biomass amount did not increase 
the total number of detected metabolites (149 ± 4) and the number of MF identified in all three 
samples slightly decreased from 142 to 136. This suggests, negative effects of sample matrix 
and increasing sample complexity had a more significant influence on HPLC-MS analysis than 
increased metabolite amount on the column resulting in column overload. Examination of the 
identifications in the cell extracts of metabolites for which LOD’s were determined (standards), a 
similar correlation was found (see Table 1). In at least two out of three analyzed samples, 7 
standard compounds were found at 0.5 ng, 23 at 5 ng, 41 at 50 ng, and 40 at 250 ng CDW per 
injection. However, several standards were not detected at injection of the highest biomass 
concentration despite being known to be present in M. extorquens AM1. Various reasons such 
as low intracellular concentrations, the method of extraction, or the stability of the compounds 
may explain this absence of detection. The results suggest that 50 ng CDW per injection are 
sufficient to identify a maximum number of metabolites. Extracted ion chromatograms from 
metabolites of various classes detected at 50 ng CDW per injection are depicted in Figure 1. 
Narrow peaks were obtained and almost no fronting or tailing was observed. Retention times 
among all samples and across all biomass concentrations was below 5%, i.e. between 0.1 and 
4.3 %. Since three analyses per sample were carried out for different scan ranges to increase 
detection sensitivity, total biomass amount was 150 ng corresponding to about 400’000 bacterial 
cells.  
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Figure 1. Extracted ion chromatograms of selected metabolites detected in cell extract of 
M. extorquens AM1 during exponential growth on methanol. Metabolites were extracted with 
cold acidified acetonitrile. Injected amount corresponded to 50 ng biomass cell dry weight. 
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CONCLUSION 
The introduced method, which combines nano-IP-RP-HPLC with nano-ESI-HRMS, 
demonstrates that very high sensitivities can be achieved in metabolome analyses. A few 
hundreds nanograms of cell extracts are enough to get a comprehensive coverage of central 
metabolism and cellular energy status. The present work was carried out with an LTQ-Orbitrap 
mass spectrometer. By hyphenating the developed nano-IP-RP-HPLC setup with more sensitive 
instruments such as latest generation triple quadrupoles, sample amounts needed for analysis 
will be further reduced. This reduction in sample need will permit for instance to miniaturize 
bacterial culture volumes or enable the analysis of high valuable cells (i.e. stem cells). The 
perspective of in situ metabolomics or even meta-metabolomics is now wide open. 
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